In contrast, the FPHA-M model exhibited a considerably increased positive rate compared with the AFP model (87.6% vs 56.7%) in total HCC and a comparable low false positive rate (6.8% vs 7.7%) in BLD. Here, AFP is linked to hepatocellular carcinoma.